Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation
about
The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cellsBim: a novel member of the Bcl-2 family that promotes apoptosisMolecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cellsProapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activityCurrent challenges and novel treatment strategies in double hit lymphomasOncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigenDevelopmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytesBcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosisBcl-2 protein expression during murine developmentLoss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic mice.Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.In situ detection of apoptosis at sites of chronic bacterially induced inflammation in human gingivaExpression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1.The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entryTreating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.bcl-2 transgene expression can protect neurons against developmental and induced cell death.Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene.Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosisNeonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death.Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patientsNon-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis.Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiationImmunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infectionImmunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomachNew characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's diseaseImmunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo.Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin's disease.Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expressionProto-oncogene analysis in multiple myelomaExpression of bcl-2 in fetal tissues suggests a role in morphogenesis.Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.Bcl-2 protein expression and long-term survival in breast cancerBcl-2 expression in normal endometrium during the menstrual cycle.Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes
P2860
Q24309225-FF114034-B007-487D-AEF0-61692E355AD8Q24316910-85AE1680-9466-4F90-A413-7357EA9B40AEQ24532974-DAACC222-EED9-4A7D-81D5-673F363DA4DDQ24629674-ED4D3CA3-11E7-46EB-9034-2735AF4803ECQ24675444-13D6DF92-2152-47AC-B1A0-511F7593FDE1Q26770385-5F706F89-7E59-4911-9384-A3D3AF8A5075Q28389449-EEBDF58C-8290-466C-8A13-379FFA8D3473Q28510299-D0DD9559-E285-401A-B546-598E0B5B6DF6Q28588677-EA07A281-5368-40FB-94E7-62C003C15778Q28593853-8B84D76F-7C48-4F24-85D5-5046AE972201Q33412907-0643C7CE-062D-4F83-A139-BCD869875332Q33493389-58F48284-E3E2-47BD-A67B-8BD9268DEA8AQ33598987-176748DC-C4C8-4D4A-8629-4FF6B13A1A6DQ33767424-6C10DA0A-35CF-41EE-80A5-DB2BBB6BA606Q33836419-2BEA3D97-0AFE-4218-898D-60C3923AF094Q33887183-A876CFEC-F386-4840-A823-6B0D653944C0Q34109682-DEB0FF50-9D83-4848-A14F-0412C23E7A17Q34116845-E9CE0138-D6AF-4951-8CF6-8BB979F81BB8Q34329305-DA763846-179A-44D5-B978-D272791759CFQ35045775-9E201FE2-E769-493C-BFD2-A49C52B2E0E8Q35094433-684BEFC1-97FF-486A-AA0F-2CCD61E4B4AEQ35168450-763549FB-E5A8-499C-A4F3-045B0E3742B8Q35207960-432F4DD6-96A2-4917-8A32-89A56C2C8994Q35588996-FE5D9D1E-A446-4AB0-BF06-CA5CDB0908AEQ35764035-386A0814-8DB3-4E76-B635-0581C7C4CFCEQ35774292-AE9B88A4-2396-480A-8B56-817DC36C3A7FQ35782275-865E524D-F8EC-4B41-9C45-896973A38C43Q35782493-8BDCE510-DE64-4DAD-8A93-F339BF96488EQ35796270-912843D7-2C42-4606-8EF8-6E8F5EAE6874Q35798201-3E227B00-2681-4EBD-A229-209E40C637F9Q35831581-AED99E59-5C88-4B83-9F3F-E5B86BF043C2Q35831766-D212E81D-31B6-4274-A0DF-A9A9C710A223Q35832022-5E3BBCA7-90D9-49A5-9FD8-001BB88C76F3Q35832489-1765EE8F-7A0F-4EAB-BFD4-AF2DDA8C4030Q35833088-E7D08285-0907-400B-8542-D2951500C1C6Q35833999-CB3D511A-B8B1-48CD-B987-EAAA5DF92F19Q35834034-FD5CCAFB-F9D0-4340-BE96-10671A2F55F4Q35834144-B4AB2A09-209F-424A-9510-6BD337460777Q35834262-D3828DBC-5AE3-42C7-938F-A53406562DEDQ35839294-71DC0EEF-6A16-46ED-B5D4-DEC96A8CB1F0
P2860
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Expression of the bcl-2 oncoge ...... 4;18 chromosomal translocation
@en
type
label
Expression of the bcl-2 oncoge ...... 4;18 chromosomal translocation
@en
prefLabel
Expression of the bcl-2 oncoge ...... 4;18 chromosomal translocation
@en
P2093
P2860
P1476
Expression of the bcl-2 oncoge ...... 4;18 chromosomal translocation
@en
P2093
P2860
P304
P407
P577
1990-08-01T00:00:00Z